Mechanisms underlying methamphetamine-induced dopamine transporter complex formation
about
Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the ratMethamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration.Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation.The new stimulant designer compound pentedrone exhibits rewarding properties and affects dopaminergic activity.Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits.Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine releaseNucleus accumbens invulnerability to methamphetamine neurotoxicity.Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicityCelecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharide.Neonatal exposure to lipopolysaccharide enhances accumulation of α-synuclein aggregation and dopamine transporter protein expression in the substantia nigra in responses to rotenone challenge in later lifeAmphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization.Methamphetamine self-administration acutely decreases monoaminergic transporter function.Protective role of neuropeptide Y Y₂ receptors in cell death and microglial response following methamphetamine injury.Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors.The neurochemical consequences of methamphetamine self-administration in male and female rats.Nomifensine alters sex differences in striatal dopaminergic function.Hippocampal glutamate transporter 1 (GLT-1) complex levels are paralleling memory training in the Multiple T-maze in C57BL/6J mice.Sex-Dependent Changes in Striatal Dopamine Transport in Preadolescent Rats Exposed Prenatally and/or Postnatally to Methamphetamine.
P2860
Q28472559-B7A73C35-D80E-480E-8FD9-797F0047ED7BQ30443801-62017362-93F0-47DD-8B68-7C523ACE5D40Q34214699-64768599-8080-46BB-A5E5-D0E21D5F42DBQ34490243-314C5459-68A2-446A-BF6B-308B202D9209Q35287229-53E03BCE-610C-4D33-826F-ECE9F94DFD8CQ35688532-2DFBBEFD-10CC-4C7D-8B40-A99B17B55193Q36316462-EF7051EB-0655-4677-9485-7B364BFF34A4Q36537905-C645413F-B365-496A-A935-1CB43A3BEBC0Q36702400-9E6D340F-CF13-4E52-AB3F-3C1E3E899105Q36767159-91825BA6-BE28-4AEE-8BEC-A634CE111891Q36798371-EBA8949D-486A-4163-BF83-78CA017B58BDQ36913314-30D5BF35-31CE-42B1-AF4B-D2C43E306C10Q37654623-7F3B529B-1571-470F-86FC-441AB4D617ACQ37656152-AF29BD0A-6C04-466C-B0F5-3DE28FCC198FQ39313146-F76F02A6-E908-4478-9DEA-42CD983CBF5EQ42220091-D9BB4138-33FC-44D6-8802-502E905809FDQ47720605-D51D208C-F647-4D6B-89DE-BBBB875117DAQ48629326-8E245AAE-7642-46CD-BE31-ABC7C4F47F3EQ50265028-A9DAC470-D521-4D9B-92E4-CD3DDBD7729CQ50534763-41DC6380-7264-46E9-8353-8B8B0EB2AA5A
P2860
Mechanisms underlying methamphetamine-induced dopamine transporter complex formation
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms underlying methamphetamine-induced dopamine transporter complex formation
@en
Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
@nl
type
label
Mechanisms underlying methamphetamine-induced dopamine transporter complex formation
@en
Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
@nl
prefLabel
Mechanisms underlying methamphetamine-induced dopamine transporter complex formation
@en
Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
@nl
P2093
P2860
P356
P1476
Mechanisms underlying methamphetamine-induced dopamine transporter complex formation
@en
P2093
Annette E Fleckenstein
Anthony J Baucum
Diana G Wilkins
Glen A Cook
Glen R Hanson
Gregory C Hadlock
James W Gibb
Jill L King
Kristen A Horner
P2860
P304
P356
10.1124/JPET.108.145631
P407
P577
2009-01-13T00:00:00Z